Prevention of Acute Radiation-Induced Skin Reaction with NPE® Camellia Sinensis Nonfermentatum Extract in Female Breast Cancer Patients Undergoing Postoperative Radiotherapy: A Single Centre, Prospective, Open-Label Pilot Study

Table 1

Demographics, status, and therapy of breast cancer and radiotherapy.

	CSNF Treatment group (n=20)	Standard care group (n=100)
Age (years)	60.2 (11.9)	62.7 (12.4)
Weight (kg)	70.5 (14.4)	75.8 (14.8)
Type of skin		Not recorded
II-Nordic Type	35%
III-Mixed Type	40%
IV-Mediterranean Type	25%
Breast size		Not recorded
B	55%
C	35%
D	10%
Breast cancer therapy
Breast conservation	90%	90%
Mastectomy	9%	5%
Endocrine Therapy	48%	55%
Chemotherapy	38%	25%
Radiotherapy
RT total dose (Gy)	55.4 (5.9)	54.8 (7.6)
Planned number of fractions	23.9 (3.8)	23.4 (4.4)
Dose/fraction (Gy)	2.3 (0.2)	2.4 (0.2)
Number of boost fractions	5.6 (0.8)	5.3 (1.4)
Dose/Boost fraction (Gy)	2.4 (0.2)	2.5 (0.1)
Hypo-fractionation	15%	25%
High tangential fields	11%	10%
Nodal irradiation	14%	30%

Mean (SD); percentage (%).